MARGIN FOREIGN EXCHANGE

Size: px
Start display at page:

Download "MARGIN FOREIGN EXCHANGE"

Transcription

1 PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE Halifax Investment Services Pty Ltd Australian Financial Services Licence No Date 28 July 2016 HALIFAX Product Disclosure Statement 1

2 IMPORTANT INFORMATION AND DISCLAIMER In addition to reading, understanding and acknowledging this PDS you must complete a Client Foreign Exchange (FX) Suitability Test. As an issuer of over-the-counter ( OTC ) derivatives (which includes Margin FX and FX Option products), Halifax is required to meet the disclosure benchmarks outlined in ASIC Regulatory Guide 227: Overthe-counter contracts for difference: Improving disclosure for retail investors. These benchmarks are not mandatory, however if they are not satisfied ASIC expects issuers will disclose on an if not, why not basis the reasons why a benchmark is not met and what they are doing to address the issue. MEETING THE DISCLOSURE BENCHMARK CLIENT QUALIFICATION Trading in Margin FX products and FX Options products is not suitable for all investors because of the significant risks involved. As many investors do not receive advice about whether or not Margin FX and FX Option products are appropriate for their objectives, financial situation and needs, ASIC expects issuers to play a role in ensuring that only investors with a sound understanding of the features and risks of Margin FX and FX Option products can open an Account and trade. This is as ASIC believes that investors who thoroughly understand the features and risks of the product will be able to determine whether Margin FX and FX Option products are an appropriate investment for them and to manage the risks associated with trading on an ongoing basis. We have established a client qualification policy which includes a client suitability test. The client suitability test includes questions which both test the investor s knowledge and also act to reiterate some aspects of the disclosure requirements for OTC Derivatives. For example, a number of questions are designed so that the correct answer will ensure that the investor recognises or appreciates risks inherent in OTC Foreign Exchange. It should be remembered that testing client knowledge is the primary aim of the client suitability test reinforcing the disclosure requirements is merely a convenient way to enhance investor understanding. You must complete your Suitability Test before you will be able to trade on an Account with Halifax. To find out more, please contact Halifax Accounts on (overseas ) after Account Opening. Decisions to invest in ( Margin FX ) and Foreign Exchange Options ( FX Options ) products carry significant risks and consequences. Margin FX products and FX Options are highly leveraged and carry a high degree of risk. Potential investors should be experienced in Margin FX and FX Option products and/or other derivative products, and understand and accept the risks of investing in such products. Refer to section 12 for more information about significant risks in trading Margin FX products. In preparing this PDS, we have not considered your personal circumstances. This document provides features and risks of Margin FX and FX Option products. Before trading in Margin FX and FX Option products, you need to be satisfied that these financial products are appropriate to your financial objectives, situation and needs. You must read and acknowledge that before opening an Account and beginning to trade you have read this PDS in its entirety and that you understand it. It is your responsibility to ensure that you fully understand the products, how they are traded and the risks involved. Halifax also recommends that you consider seeking financial, legal, taxation and other professional advice to ensure that you fully understand Margin FX and FX Option products and that they are appropriate for you before you begin trading in these products. To the extent permitted by law, neither Halifax nor its affiliates accepts any responsibility for errors or misstatements, negligent or otherwise, nor for any direct, indirect, consequential or other loss arising from any use of these documents and/or further communication in relation to them. 2 HALIFAX Product Disclosure Statement

3 DO YOU HAVE ALL THE RELEVANT DOCUMENTS? This PDS is subject to the detailed provisions of the Client Services Agreement and Financial Services Guide ( FSG ). You must ensure you have read and fully understand the Client Services Agreement, the FSG and this PDS. Index 1. Introduction Terms and Conditions The Purpose of this PDS Changes to this PDS The Financial Products this PDS Covers... 5 BEFORE YOU TRADE IN MARGIN FX AND FX OPTIONS, YOU MUST CAREFULLY CONSIDER WHICH TRADING PLATFORM BEST SUITS YOUR NEEDS It is very important for you to understand the Trading Platforms and, where relevant, our arrangements with our Platform Counterparties, as they can affect key terms of the Margin FX and FX Option Transactions you enter into and can fundamentally change the nature of your legal rights in respect of a Margin FX and FX Option and your Account in general. Your choice of Trading Platform for a Margin FX and FX Option Transaction can significantly impact: the credit risk you take in respect of your Trading Platform including the extent to which your credit risk to us is supported by positions we take with third party Platform Counterparties; the fees and costs you are charged for your Margin FX and FX Option Transactions; and the range of Margin FX and FX Option Transactions you are able to enter into. In order to enter into a Margin FX or FX Option Transaction, you must select a Trading Platform However, in some limited circumstances, we may allow you to enter into a Margin FX or FX Option Transaction without choosing a Trading Platform. 6. About Halifax Purpose of Margin FX products RG227 Disclosure Benchmarks Key Features of Margin FX Key Features of FX Option Contracts Key Benefits Significant risks Margin obligations Opening and Closing Out a Margin FX Position Trading Platforms Trading hours Trading examples Charges, fees and other amounts payable for Margin FX Charges, fees and other amounts payable for FX Option Contracts Confirmation of transactions Market information No cooling off arrangements Taxation implications Dispute resolution Privacy Glossary of terms Annexure A: Orders types you can place with Halifax Schedule A Schedule B Schedule C Schedule D Schedule E HALIFAX Product Disclosure Statement 3

4 1. Introduction This PDS is dated 28 July 2016 and is issued by Halifax Investment Services Pty Ltd ( Halifax ). Halifax is an unlisted Australian company (ABN ), that holds an Australian financial services licence issued by the Australian Securities and Investments Commission ( ASIC ) (AFS Licence number ). This PDS has been prepared by Halifax as the issuer of Margin FX and FX Option products. All of the Margin FX and FX Option products offered by Halifax under this PDS are over the counter ( OTC ) derivative products. While this PDS is designed to assist you in making an informed decision regarding opening an Account and trading Margin FX and FX Option products, the information in it is general information only and does not take into account your personal objectives, financial situation and needs. We also refer you to the detailed provisions of the Client Services Agreement and the FSG. Before making a decision to acquire the financial products described in this PDS you should read this PDS, the FSG and Client Services Agreement and be satisfied that any trading you undertake in relation to the Margin FX and FX Option products described in this PDS is appropriate in view of your objectives, financial situation and needs. You can access the FSG and the Client Services Agreement from our website or, by calling Halifax and requesting that a paper copy be provided to you free of charge. Refer to the glossary of terms in section 26 for definitions we use in this PDS. 2. Terms and Conditions This PDS and the FSG set out important information about the financial products and services Halifax offers and about Halifax itself. Additional legal terms governing your dealing with us are set out in: your Client Services Agreement with us; any supplementary terms for particular financial products; and any supplementary terms for any electronic Trading Platform which you use. You will need to enter into a Client Services Agreement by completing the application form and submitting it to us. The Client Services Agreement sets out the general legal terms of your dealings with us for the products covered by this PDS and also for dealings not covered by this PDS (such as trading in other financial products we offer). By completing an application form and submitting it to us you agree to the terms of the Client Services Agreement and this PDS. To the extent of any inconsistency between your Client Service Agreement and this PDS, unless expressly agreed otherwise, this PDS shall prevail. 3. The Purpose of this PDS Under the Corporations Act, a retail client must generally receive a PDS before acquiring a financial product. The PDS is the document that sets out the significant features of a financial product, including its risks, benefits, costs and fees and other related information. The purpose of this PDS is to provide you with sufficient information to make an informed decision in relation to the acquisition of our financial products. You may also use this PDS to compare the financial products described with similar financial products offered by other issuers i.e. other Margin FX and FX Options providers. This PDS seeks to explain to you about our financial products in a clear, concise and effective manner. When we use the terms Halifax, we, our or us in this PDS, the reference is to Halifax, the issuer of the Margin FX and FX Option products described in this PDS. When we use the term you we mean you as the applicant for or holder of financial products issued by us. When we refer to client we mean you or another applicant for or holder of Margin FX or FX Option products issued by us. This PDS is an important document and provides you with key information about certain financial products that we offer. Margin FX and FX Option products can be highly leveraged and speculative with a high degree of risk. Potential investors should understand the risks of investing in Margin FX and FX Option before making any decision to invest. Before trading in the Margin FX and FX Option products referred to in this PDS you should give consideration to your objectives, financial situation and needs. We recommend that you take all reasonable steps to fully understand the possible outcomes of trades and strategies in relation to the Margin FX and FX Option products offered. You should also be aware of the risks involved and be satisfied that trading in these products is suitable for you in view of your financial circumstances. If you have any questions in relation to this PDS, please do not hesitate to contact us (our contact details are in section 6). We are required to give you this PDS because we are the issuer of the financial products described in it. 4 HALIFAX Product Disclosure Statement

5 Other jurisdictions The distribution of this PDS in jurisdictions outside Australia may be subject to legal restrictions. Any person who resides outside Australia who gains access to this PDS should comply with any such restrictions as failure to do so may constitute a violation of financial services laws. This PDS does not constitute an offer or invitation in relation to a financial product to any US persons or in any place in which, or to any person to whom, it would not be lawful to make such an offer or invitation. 5. The Financial Products this PDS Covers The Margin FX and FX Option products offered under this PDS are OTC derivative contracts. A derivative contract is a contract that derives its value by reference to one or more assets (called the Underlying Instrument ) and an OTC derivative is a derivative that is traded off-market rather than on an exchange such as a stock exchange or futures exchange. When you transact in Margin FX and FX Options, you will transact with Halifax (acting in a principal capacity). The Application of this PDS We have recently made a number of fundamental changes to the terms of the Margin FX and FX Option products which are reflected in this PDS. This PDS relates to Accounts opened, or for which a Trading Platform is changed, after the date of this PDS. If you are one of our existing clients and you have entered into a Client Services Agreement before the date of this PDS, your Transactions will continue to be governed by your existing Client Services Agreement and the PDS under which you invested until 31 December 2016 or, if earlier, the date the Trading Platform for your Account is changed. After that date all your Transactions (including those opened on or before that date) will become governed by this PDS. Our existing clients can elect to transition to the terms of the Margin FX and FX Option products under this PDS earlier than 1 January 2017 by contacting us and agreeing to vary the terms of your Client Services Agreement. You must make this election before you will be permitted to trade on the Halifax Pro or the Halifax Plus Trading Platforms. 4. Changes to this PDS This PDS is subject to change from time to time and may be updated on our website A copy can be downloaded from our website or, by calling us and requesting that a paper copy be provided to you free of charge. If any new information is materially adverse information, we will issue a new or supplementary PDS with the new information. If the new information is not materially adverse, we may not issue a new PDS or supplementary PDS but you will be able to find the updated information on our website at or by contacting us. Our contact details are set out in section 6. Margin FX Margin FX products are financial products which are agreements between you and Halifax to trade the difference arising from movements in the level of an Underlying Instrument that is an Exchange Rate for two currencies or for a limited number of precious metals (referred to as the Underlying Exchange Rate ). Margin FX products have no fixed expiry dates, are not standardised contracts and have no fixed contract size. As a party to a Margin FX Transaction, you can, on Closing Out the Transaction, be paid an amount (representing a gross profit) or be required to pay an amount (representing a gross loss) arising from movements in the Underlying Exchange Rate. The Underlying Instrument for a Margin FX Transaction is referred to as the Exchange Rate. The Exchange Rate can be either the price of one currency expressed in the terms of another currency ( FX Transactions ) or the price of a precious metal expressed in a specified currency or precious metal ( Metal Transactions ): For FX Transactions: the Exchange Rate is the price of one currency in terms of another currency (called a Currency Pair ). For example, the Exchange Rate might be the price of the Australian dollar (AUD) in terms of the United States dollar (USD). If the current Exchange Rate for the AUD against the USD (AUD/USD) is , this means that one AUD dollar equates to, or can be exchanged for, USD or 90 US cents. For Metal Transactions: the Exchange Rate is the price of one precious metal (limited to either gold or silver) in terms of a specified currency or precious metal (called a Metal Pair ). For example, the Exchange Rate might be the price of the spot gold (XAU) in terms of USD. If the current Exchange Rate for gold as against the USD (XAU/USD) is , this means that 1 ounce of spot gold equates to, or can be exchanged for, USD 1, HALIFAX Product Disclosure Statement 5

6 All Margin FX Transactions remain open until they are Closed Out. This occurs where the client enters into an equal and opposite Transaction and the two positions are offset against each other. Importantly, trading Margin FX does not result in the ownership by you of any actual currency or precious metal to which the Margin FX Transaction relates. Margin FX Transactions do not result in the physical delivery of the relevant foreign currency or precious metal, but instead are cash settled. FX Options Option contracts traded over Margin FX products are referred to as FX Option Contracts. The buyer of an FX Option Contract pays a Premium in exchange for the right, but not the obligation, to enter into a Margin FX Transaction with the seller at a predetermined Exchange Rate (called the Exercise Rate ) on the Expiry Date. From the seller s viewpoint, the seller has no right other than a right to the Premium. The seller will be under an obligation to enter into a Margin FX Transaction at the Exercise Rate of the FX Option Contract if the FX Option Contract is validly exercised by the buyer. If the FX Option Contract is exercised at the Expiry Date, this will result either in a Cash Settlement or the establishment of a Margin FX Transaction between the buyer and the seller. Refer to section 10 for further details on FX Options. You can terminate your exposure under an FX Option Contract before the Expiry Date by: where you are the buyer of the FX Option, selling to Halifax a corresponding FX Option; or where you are the seller of the FX Option, buying from Halifax a corresponding FX Option. What are the Trading Platforms and how do they affect my Margin FX and FX Options? To enter a Transaction with us, generally you must select one of the Trading Platforms through which to do so. Each Trading Platform has a separate online interface and so you must arrange through us for access to each Trading Platform you want to use. Each individual Transaction will be through a specific Trading Platform and you cannot transfer open positions from one Trading Platform to another. There are two ways in which we can we can issue Margin FX and FX Option product to you in a Transaction. 1. As a straight through processor, which means that we essentially hedge 100% of our exposure to you under the Transaction by entering into an equivalent matching transaction with the relevant Platform Counterparty (referred to as the Hedge Transaction ). 2. Alternatively, we can elect not to hedge, or to hedge less than 100% of, our exposure to you under the Transaction. If you enter into a Transaction with us using any Trading Platform other than Halifax Pro or Halifax Plus, we will only issue the Margin FX or FX Option product to you as a straight through processor and, therefore, essentially 100% of our exposure to you will be hedged with the relevant Platform Counterparty. If you enter into a Transaction with us using the Halifax Pro or Halifax Plus Trading Platforms, we will decide at our discretion whether we hedge our exposure to you with the Platform Counterparty and, if we do decide to hedge our exposure, how much of the exposure we hedge. Further, we may decide to alter our hedging arrangements during the time any Margin FX or FX Option product we issue to you remains open. In making these decisions, we will be guided by our market risk policy (see Benchmark 3 in Section 8 for further detail). It is very important for you to understand whether we enter into hedging arrangements with our Platform Counterparties and the nature of those arrangements as they can affect a number of features of your Margin FX or FX Option product and fundamentally change the nature of your legal rights in respect of a Transaction and your Account in general. In particular, your choice of Trading Platform for a Transaction and the Trading Platforms we offer clients generally (regardless of whether you use all of them) has the following impacts. Whether, and the extent to which, we hedge our exposure as issuer of Margin FX or FX Option products. If we decide not to hedge 100% of our exposure to Margin FX or FX Option products we issue through the Halifax Pro or Halifax Plus Trading Platforms, we will only be able to rely on our own financial resources to meet any unhedged exposures. As our exposure to Margin FX or FX Option products are not segregated between Trading Platforms, this reliance and the credit risk associated with it are relevant to all our clients, not just those who trade through the Halifax Pro or Halifax Plus Trading Platforms. The credit risk you take on the Platform Counterparty for your Trading Platform. 6 HALIFAX Product Disclosure Statement

7 The fees and costs you are charged for the relevant Transaction. The range of Margin FX or FX Options Transactions you are able to enter into. Transaction, you transact with us in a principal capacity. That is, your contractual relationship is with us only, and you have no rights of recourse to the relevant Platform Counterparty, or to any other person. What is the difference between a Trust Account Platform and a Non Trust Account Platform? There is a fundamental difference in the way financial services providers treat the balance of your Account depending on whether you use a Trust Account Platform or a Non Trust Account Platform. For Accounts opened, or for which a Trading Platform is changed, after the date of this PDS, all Trading Platforms are Non Trust Account Platforms. For Accounts opened on or before the date of this PDS, some Trading Platforms will continue to be Trust Account Platforms until the Account transitions to this PDS in accordance with section 3. See the PDS under which you invested for details. How we treat your money under Trust Account Platforms In contrast to Non Trust Account Platforms, for the Trust Account Platforms (which we do not offer under this PDS), amounts paid to the relevant financial services provider are deposited into a client trust account maintained by that provider. This means that client funds (and property) are segregated from the provider s own funds (or property). How we treat your money For Non Trust Account Platforms, all amounts you pay to us will be absolutely owned by us from the time of receipt and will be paid into our account. There will be no segregation of this money or property. This means that those funds are available to pay our general creditors if we become insolvent. In brief, this means that those funds are not available to pay the provider s general creditors if it becomes insolvent. How do I take credit risk on the Platform Counterparty for my Trading Platform? For each Margin FX and FX Options Transaction you enter into, we will (or, in the case of Margin FX and FX Options Transactions you enter into through Halifax Pro or Halifax Plus, may) hedge our exposure to you by entering into an equivalent transaction with the relevant Platform Counterparty. However, when you enter into a However, you still take credit exposure on the Platform Counterparty because, under the terms of your Transaction, our obligations to you are linked to the performance by the Platform Counterparty of its obligations under the Hedge Transaction. That is, to the extent the relevant Platform Counterparty fails to perform its obligations under the Hedge Transaction for your Transaction, our obligations to you in respect of your Transaction will be reduced accordingly. This means that if the relevant Platform Counterparty becomes insolvent, you might lose some or all of the balance of your Account in that Trading Platform (even though we might continue to be solvent). In addition, you might face considerable delays before you are able to access the amount (if any) that is able to be recovered from the Platform Counterparty. Do I also take credit risk on Halifax? Yes. Your rights against us in respect of your Account are unsecured contractual rights. Our establishment in January 2016 of the Halifax Pro Trading Platform and of Halifax Plus Trading Platform in July 2016 has resulted in a change to our approach to the hedging of our exposure to Transactions we enter into. Traditionally, we have operated as a straight through processor, which means that we essentially hedge 100% of our exposure to the Transactions we enter into. While we will continue this approach for Transactions we enter into through our existing Trading Platforms, we may decide not to hedge, or to hedge less than 100% of, our exposure to Transactions we enter into through the Halifax Pro or Halifax Plus Trading Platforms. In making these decisions, we will be guided by our market risk policy (see the explanation under Benchmark 3 in section 8 for further detail). The fact that we may now decide not to hedge, or to hedge less than 100% of, our exposure to some Transactions is relevant to, and likely to increase, our credit risk because we will only be able to rely on our own financial resources to meet any unhedged exposures which crystalize. As our exposure to Transactions are not segregated between Trading Platforms, this is relevant for all our clients, including those who do not trade through the Halifax Pro or Halifax Plus Trading Platforms. HALIFAX Product Disclosure Statement 7

8 How does my choice of Trading Platform affect the fees and costs I am charged? The fees and costs you are charged will differ depending on your choice of Trading Platform. This is because the fees we charge you reflect the fees that we are charged under the Hedge Transaction and/ or in the case of Transactions entered into through the Halifax Pro or the Halifax Plus Trading Platforms, and compensation for any exposure we decide not to hedge (plus various spreads or margins we apply for our profit). The fees and costs charged in respect of each Trading Platform are described in section 18 and 19 and in the tables in Schedules A-B. There can be considerable differences in the fees charged in respect of each Trading Platform, so it is very important that you understand the various fee options so that you can choose which Trading Platform best suits your needs. 6. About Halifax We are the issuer of this PDS and the issuer of the Margin FX and FX Option products referred to in this PDS. In accordance with our AFS Licence, we are authorised by ASIC to advise, deal and make a market to both retail and wholesale clients in derivatives. Margin FX and FX Option products are derivatives. Pursuant to our AFS Licence, among other things, we are also authorised to provide general and/or personal financial product advice in relation to, and to deal in, the following products for both retail and wholesale clients: (i) deposit and payment products limited to basic deposits; (ii) interests in managed investment schemes excluding investor directed portfolio services; (iii) foreign exchange contracts (and make a market); (iv) securities; and (v) miscellaneous financial investment products (limited to managed investment warrants). All enquiries to us should be made during business hours to the Operations Manager. Our contact details are: The Operations Manager Halifax Investment Services Pty Ltd Governor Phillip Tower Level 49, 1 Farrer Place Sydney NSW 2000 Phone: ( ) Facsimile: operations@halifaxonline.com.au Website: 7. Purpose of Margin FX and FX Option products Margin FX and FX Option products are generally used for one of two purposes hedging or speculating: Margin FX and FX Option products can provide people with a facility for managing the risks associated with changing prices for certain investments. This strategy is known as hedging. Margin FX and FX Option products are also traded by speculators, who trade in the anticipation of profiting purely from changing prices in the Underlying Instrument. Generally, trading Margin FX and FX Option products allows you to leverage your positions to take a much greater exposure than if you were to transact directly in the relevant currency or precious metal. Trading in Margin FX and FX Option products does, however, involve significant risk. Transactions should only be entered into by traders and investors who understand the nature and extent of their rights, obligations and risks (for more information on risks refer to section 12). 8 HALIFAX Product Disclosure Statement

9 8. RG227 Disclosure Benchmarks ASIC Regulatory Guide 227 requires issuers of over-the-counter (OTC) derivatives to publish certain information addressing a range of disclosure benchmarks. These benchmarks are required to be addressed on an if not, why not basis, and are intended to assist retail investors to properly understand the complexity and risks of trading in OTC derivative products, particularly with regard to leverage. There are 7 disclosure benchmarks required to be addressed, our compliance with each benchmark is addressed in the following table. Benchmark Description Explanation Further Information Benchmark 1: Client qualification An issuer should maintain and apply a written client qualification policy that: (a) sets out the minimum qualification criteria that prospective investors will need to demonstrate they meet before the issuer will agree to open a new account on their behalf; (b) outlines the processes the issuer has in place to ensure that prospective investors who do not meet the qualification criteria are not able to open an account and trade in Margin FX or FX Option products; and (c) requires the issuer to keep written records of client assessments. Trading in Margin FX and FX Option products is not suitable for all investors because of the significant risks involved. We do not provide clients with personal advice about whether Margin FX and FX Option products are appropriate for them. However, we maintain and apply a client qualification policy to help us assess whether clients have a sound understanding of the features and risks of Margin FX and FX Option products. Our policy requires us to assess prospective clients against minimum qualification criteria for this purpose. Our assessment involves administering a client Margin FX suitability test which includes questions designed to inform us about such matters as: your previous trading experience in financial products generally, and Margin FX and FX Option products in particular; your understanding of leverage, margins and volatility; your understanding of the key features of Margin FX and FX Option products; your understanding the trading process and relevant technology associated with the Trading Platforms; your ability to monitor and manage the risks of trading; and your understanding that only risk capital should be traded. We then assess your test answers against a grading scheme to determine whether you meet the minimum qualification threshold. Currently, our policy requires us to maintain a written record of your assessment for the duration of the period you have an Account and for at least seven years thereafter. Our practice differs from the benchmark in that we may permit you to open an Account before we complete our assessment. However, you will not be able to enter into any Transactions through your Account until we complete our assessment and, through it, you demonstrate to us that you satisfy the minimum qualification criteria. Page 2. 9 HALIFAX Product Disclosure Statement

10 Benchmark Description Explanation Further Information Benchmark 2: Opening collateral An issuer should generally only accept cash or cash equivalents from investors as opening collateral when establishing an account to trade in Margin FX and FX Option products. If credit cards are used to open accounts, an issuer should accept no more than $1000 via credit card to fund the account. We only permit clients to open an Account and commence trading with cleared funds deposited into the bank account we nominate. Typically, this will require you to make a cash deposit or electronic fund transfer to a bank account nominated by us or to authorise us to charge an amount to a credit card (but only to certain amounts on credit card). We may accept bank and other cheque deposits but will require clearance of funds before trading can commence. Our practice differs from the benchmark in that we may decide to accept an authorisation to charge more than AU$1,000 to a credit card. This is because we have a process in place to address the suitability of credit card deposits as opening collateral. We utilise a tiered range of internal limits established with our payment processor, based on an individual client s annual income, and accordingly may accept higher amounts as an initial deposit depending on the size of your annual income. If you are considering funding Account collateral with borrowed funds (including by charging a credit card), you should consider how you will fund their repayment and any financing charges, particularly if you suffer trading losses. Along with all investors in Margin FX and FX Option products, you should also consider whether you have access to sufficient financial resources to fund Margin Calls as and when they may arise. Halifax will only act on funds that have cleared, so we recommend that you maintain sufficient Margin in your Account at all times to maintain your open positions. No financial products or other assets will be accepted as collateral to open an Account, although we may accept certain financial products as collateral to meet Margin Calls in special agreed circumstances. Trading in OTC derivative products carries a high level of risk and returns are volatile. The risk of loss in trading can be substantial, and you can incur losses in excess of the capital you have invested. Accordingly, you should only trade with risk capital i.e. money you can afford to lose, and which is excess to your financial needs/obligations. Sections 11 and HALIFAX Product Disclosure Statement

11 Benchmark Description Explanation Further Information Benchmark 3: Counterparty risk Hedging An issuer should maintain and apply a written policy to manage its exposure to market risk from client positions, which: (a) includes the factors it takes into account when determining if hedging counterparties are of sufficient financial standing; and (b) sets out the names of those hedging counterparties (as they stand from time to time). Policies should be displayed in an up-to-date form on the issuer s website. We maintain and apply a market risk policy the purposes of which include to: manage our exposure to market risk from the Transactions we enter into with our clients, including by determining whether, and the extent to which, we enter into Hedge Transactions with Platform Counterparties; and initially assess and thereafter monitor Platform Counterparties by applying risk assessment criteria to determine that they are of sufficient financial standing, are licensed by a comparable regulator and are of sound reputation. Our market risk policy is a component of our financial risk management strategy. The policy requires that we essentially hedge 100% of our exposure to Transactions we enter into through a Trading Platform (other than Halifax Pro or Halifax Plus) by entering into an equivalent Hedge Transaction with the relevant Platform Counterparty. As a consequence, it is likely that we will elect not to accept an order if we cannot enter into an equivalent cost-effective Hedge Transaction. Also, we may elect to not to accept an order (or Close Out an open position) if we have concerns about the creditworthiness or good standing of the relevant Platform Counterparty. It is important to note that these are just two examples of when we may elect not to accept an order or to Close Out an open position we may take these actions, in our absolute discretion, for any other reason. In the case of Transactions we enter into through the Halifax Pro or the Halifax Plus Trading Platforms, the policy permits us to take on market risk to facilitate prompt execution of Transactions. This will occur when we agree to enter into a Transaction ahead of entering into an equivalent Hedge Transaction. From time to time, this is likely to result in us maintaining exposures beyond the shortterm because we have not been able to enter into a cost-effective equivalent Hedge Transaction. In other cases, we may decide to not enter into an equivalent Hedge Transaction at all or to enter into one for less than 100% of our exposure to the Transaction. The policy permits us to do this, within set exposure limits, if: as a result of our clients overall market positions, we determine that we have a natural hedge of our exposure to the Transaction; or otherwise, within conservative exposure limits based on our clients overall market positions and their historical trading patterns. The policy prohibits us from taking proprietary positions based on expected movements in the value of Underlying Instrument. The policy includes methodology for setting exposure limits that reflect a conservative risk appetite, the extent of our financial resources and the nature and extent of any other financial risks we are exposed to, and the expected liquidity and volatility of Underlying Instruments (and equivalent financial products). The policy requires real-time monitoring of our exposures against these limits and sets out the steps that are required to be taken if they are exceeded. Sections 5, 6 and HALIFAX Product Disclosure Statement

12 Benchmark Description Explanation Further Information Benchmark 4: Counterparty risk Financial resources An issuer should maintain and apply a written policy to maintain adequate financial resources, which details how the issuer: (a) monitors its compliance with its Australian financial services (AFS) licence financial requirements; and (b) conducts stress testing to ensure it holds sufficient liquid funds to withstand significant adverse market movements. You have no rights of recourse against a relevant Platform Counterparty in respect of any Transaction you enter into because we transact with each Platform Counterparty in respect of our Hedge Transactions solely as principal. However, you still take credit risk on the Platform Counterparty (in addition to taking credit risk on us). This is because our obligations to you are subject to the performance by the Platform Counterparty of its obligations to us under the corresponding Hedge Transaction: a failure of a Platform Counterparty to perform its obligations under a Hedge Transaction will result in our obligations to the relevant client under the corresponding Transaction being reduced accordingly. Therefore, if an insolvency event occurs in respect of the Platform Counterparty for your Trading Platform, you might lose some or all of the balance of your Account in that Trading Platform (even though we might continue to be solvent). In addition, you might face considerable delays before you are able to access the amount (if any) that is able to be recovered from the Platform Counterparty. The relevant Platform Counterparty for each Trading Platform, as at the date of this PDS, is set out in section 15. Any changes will be disclosed in our market risk policy, a copy of which is available from our website: We maintain and apply a financial adequacy policy to ensure the ongoing maintenance of adequate financial resources. The policy reflects the financial requirements imposed on us as conditions under our AFSL. As a retail OTC derivative issuer and AFSL holder, these requirements include: base level financial requirements of solvency and positive net assets; tailored cash needs requirement involving quarterly rolling cash flow projections of our anticipated cash flow expenses and NTA requirements; tailored audit reporting requirement; and NTA requirement which requires that we maintain net tangible assets of $1 million or 10% of our average revenue (whichever is greater) at all times and comply with reporting triggers if our net tangible assets fall below 110% of this amount. Pursuant to the policy, we have in place a system for monitoring our compliance with these requirements. The monitoring system involves: real-time monitoring of, and daily reporting on, our market exposures; weekly reconciliation of, and reporting on, all trading activities; monthly review of, and reporting on, all trading activities by an external advisor as part of its preparation of monthly management accounts; quarterly review of cash flow projections in conjunction an external advisor; and annual financial and compliance reporting and the external audit of those reports. Section HALIFAX Product Disclosure Statement

13 Benchmark Description Explanation Further Information A copy of our most recent audited financial statements are available from our website: Following the launch of the Halifax Pro amd Halifax Plus Trading Platforms, we have updated the policy to require quarterly stress testing of our market exposures, the purpose of which is to ensure that, if there was a significant adverse market movement to which we had exposure, we would continue to have sufficient liquid resources to meet our obligations to clients without needing to have recourse to client money to do so. Benchmark 5: Client money An issuer should maintain and apply a clear policy on its use of client money, including whether it uses money deposited by one investor to meet the margin or settlement requirements of another. There is a fundamental difference in the way financial services providers may treat the balance of accounts you open with them depending on whether they offer Trust Account Platforms or Non Trust Account Platforms. Non Trust Account Platforms We only offer Non Trust Account Platforms under this PDS. This means amounts you pay to us will be treated as amounts paid to purchase a financial product from us (or an increased interest in a financial product) and will be paid into our account and will be absolutely owned by us from the time of receipt. There will be no segregation of your money or property. In brief, this means that those funds are available to pay general creditors if we become insolvent. In that scenario, you may lose some or all of your client money and/or experience long delays before it is refunded to you. Trust Account Platforms For Trust Account Platforms (which we do not offer under this PDS), funds you transfer to the relevant financial services provider are paid into a client trust account that provider maintains in accordance with the Corporations Act. Although funds standing to the credit of a client trust account maintained by a financial services provider will not be available to pay general creditors if the provider becomes insolvent, a client of that provider may be nevertheless exposed to some counterparty risk with respect to its funds (i.e. the client may not receive all of its money back) if, for example, those funds are used to meet obligations incurred by the provider in connection with dealings in financial products, including dealings on behalf of other clients. Sections 11.1 and HALIFAX Product Disclosure Statement

14 Benchmark Description Explanation Further Information Benchmark 6: Suspended or halted underlying assets An issuer should not allow new Margin FX and FX Options positions to be opened when there is a trading halt over the underlying asset, or trading in the underlying asset has otherwise been suspended, in accordance with the rules of the relevant market. Benchmark 7: Margin calls An issuer should maintain and apply a written policy about its margining practices, which details: (a) how the issuer will monitor client accounts, to ensure that it receives early notice of accounts likely to enter into margin call; (b) what rights the issuer may exercise in relation to client accounts, including the right to make a margin call or close out positions; and (c) when the issuer will exercise these rights, and what factors it will take into account in deciding whether to do so. Regardless of the issuer s other margining practices, the policy should require the issuer to take reasonable steps to notify investors before closing out positions. By reasonable steps we mean giving notice to investors, according to a pre-agreed method (e.g. telephone message, , SMS), that a position will shortly be closed out. If an issuer has a default method of communication, rather than agreeing this with each investor, this should be clearly explained in the PDS. An Underlying Instrument may be placed in a trading halt on the relevant exchange in various circumstances. Additionally, it may be suspended or delisted in certain circumstances. We will not enter into a Transaction with you if the Underlying Instrument is subject to trading halt or suspension or has been delisted your order will remain pending until such time as trading in the Underlying Instrument resumes. However, we may in our discretion cancel the order. You should also note that we may, in our discretion, Close Out any open Margin FX or FX Option product if the Underlying Instrument becomes the subject of a trading halt or suspension or is delisted. Alternatively, we may, in our discretion, increase the Margin Requirements or re-price the Transaction. We maintain and apply a written policy detailing our margining practices. This details our rights to make Margin Calls and closing out of positions when such calls are not met in a timely manner, and what factors we consider when exercising such Close-Out rights. Clients are required to monitor all open positions themselves on a real-time basis intraday, to ensure changing Margin Requirements are identified and actioned in a timely manner. Please note that certain market conditions or events may trigger extreme volatility, requiring urgent funds to be applied to retain your open positions. If we decide to make a Margin Call, we will generally do so through pop-up screens or screen alerts on the Trading Platform. You will only have access to these when you are logged-on to the relevant Trading Platform. Our practice may differ from the benchmark in that we do not warranty that we will make a Margin Call before Closing Out an open position or that any steps we take to communicate a Margin Call will be reasonable it is your responsibility to monitor your Account for changing Margin Requirements. We have adopted this practice because you have direct access to your Trading Platforms from which you can monitor your Account. If you are unable to access a Trading Platform through which you have open positions for any reason, you should contact us urgently to discuss the matter. If your inability to access a Trading Platform is likely to persist, you should consider closing all your open positions. We do not accept any responsibility for your inability to access a Trading Platform. Sections 12.1 and Sections 12.1 and HALIFAX Product Disclosure Statement

15 9. Key Features of Margin FX Margin FX products are a speculative investment and involves a high degree of risk. It is not suitable for all investors. You should not transact in Margin FX unless you are experienced in derivatives, leveraged products and foreign exchange contracts, and you understand the risks of transacting in Margin FX. You are responsible for the selection of the Currency Pair or Metal Pair for each Transaction. The performance of a Margin FX Transaction will depend on movements in the Underlying Instrument for the Currency Pair or Metal Pair you select and on your trading strategy. The value of an investment in Margin FX can change rapidly and by significant amounts at any time Differences between FX Transactions and Metal Transactions As noted in section 5 above, Margin FX Transactions can be either FX Transactions or Metal Transactions. FX Transactions FX Transactions are derivative products on which you can make a profit or incur a loss if the value of one currency appreciates or depreciates (depending on the direction of the trade) when compared against another currency, without having to transact in the actual currencies itself. FX Transactions are available in most widely traded currencies. In order to enter into an FX Transaction, you must select two currencies (called a Currency Pair). The Underlying Instrument for an FX Transaction is the Exchange Rate of the Currency Pair (called the Underlying Exchange Rate). For example, AUD/USD is the Exchange Rate of the AUD in terms of the USD. If the AUD/USD is , this means that one Australian dollar can be exchanged for 95 US cents. All FX quotations are made up of two currencies: the Base Currency and the Terms Currency. The Base Currency can be identified as being the first currency in the Currency Pair. The second currency in your Currency Pair is referred to as your Terms Currency. So, for an FX Transaction where the Underlying Exchange Rate is AUD/USD, AUD will be the Base Currency and USD will be the Terms Currency. Unlike contracts traded on an exchange, OTC products are not standardised. The terms of an FX Transaction are individually tailored to the particular requirements of the parties involved in the contract i.e. us and the client. The terms involved in the negotiation of FX Transactions are: (a) the Currency Pair; (b) the amount of the Base Currency to which the Transaction relates (called the Notional Value ); (c) the Exchange Rate at which such currencies are to be exchanged; and (d) the Value Date for the Transaction (see section 9.7). FX Transactions are OTC derivative products with Halifax acting as counterparty (and principal) in its dealings with you. It is a transaction between you and us and can only be entered into with us and Closed Out with us. It is not possible to Close Out the FX Transactions with any other party. FX Transactions are subject to Margin Requirements and marked to market on at least a daily basis (for more information refer to section 13). Metal Transactions Metal Transactions are the same as FX Transactions, except that: Under Metal Transactions you make a profit or incur a loss if the value of a precious metal (limited to gold or silver) appreciates or depreciates (depending on the direction of the trade) when compared against a currency or precious metal (as compared to two currencies under FX Transactions). In order to enter into a Metal Transaction, you must select the relevant precious metals or precious metal and currency (called a Metal Pair). The only precious metals that are available to form part of the Metal Pair are gold and silver and are always considered the Base Currency. However, most widely traded currencies are available to make up the Terms Currency of the Metal Pair along with either gold or silver. For example, if the Underlying Exchange Rate for a Metal Transaction is XAU/USD which is spot gold in terms of US dollar, then gold will be the Base Currency and USD will be the Terms Currency. The Underlying Exchange Rate for Metal Transactions is the price of the precious metal in your Metal Pair in terms of the specified currency in your Metal Pair. For example, XAU/USD is the Exchange Rate of the gold in terms of the USD. If the XAU/USD is , this means that one ounce of gold can be exchanged for US$1, Quotes A quote for a Margin FX product represents the bid/ask spread for the Underlying Exchange Rate. For example, for a Margin FX Transaction where the Underlying Exchange Rate is the Exchange Rate for AUD/USD, the Margin FX may be quoted as / HALIFAX Product Disclosure Statement 15

MARGIN FOREIGN EXCHANGE

MARGIN FOREIGN EXCHANGE PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE Halifax Investment Services Limited Australian Financial Services Licence No. 225973 Date 20th October 2014 HALIFAX Product Disclosure Statement 1 IMPORTANT

More information

CONTRACTS FOR DIFFERENCE

CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE Halifax Investment Services Limited Australian Financial Services Licence No. 225973 Date 20th October 2014 HALIFAX Product Disclosure Statement 1

More information

MARGIN FOREIGN EXCHANGE AND FOREIGN EXCHANGE OPTIONS

MARGIN FOREIGN EXCHANGE AND FOREIGN EXCHANGE OPTIONS CLIENT SERVICE AGREEMENT Halifax New Zealand Limited Client Service Agreement Product Disclosure Statement for MARGIN FOREIGN EXCHANGE AND FOREIGN EXCHANGE OPTIONS Halifax New Zealand Limited Financial

More information

Margin FX and CFDs Product Disclosure Statement 26 April 2016

Margin FX and CFDs Product Disclosure Statement 26 April 2016 Margin FX and CFDs 26 April 2016 Issuer: Forex Capital Trading Pty Ltd AFSL No. 306400 and ABN 69 119 086 270 1 P a g e 1. Important Information 1.1 About this PDS This PDS is issued by Forex Capital Trading

More information

PRODUCT DISCLOSURE STATEMENT Spot Forex, FX Options and CFDs

PRODUCT DISCLOSURE STATEMENT Spot Forex, FX Options and CFDs GAIN Capital FOREX.com Australia Pty Ltd ACN 138 414 605 Level 1, 62 Pitt Street, Sydney, NSW 2000 PRODUCT DISCLOSURE STATEMENT Spot Forex, FX Options and CFDs AUSTRALIAN FINANCIAL SERVICES LICENCE NO:

More information

ARUDA PTY LTD. PRODUCT DISCLOSURE STATEMENT Over- the- Counter Contracts for Difference. Online Trading Facility. Issue Date: 28 May 2012 V5.

ARUDA PTY LTD. PRODUCT DISCLOSURE STATEMENT Over- the- Counter Contracts for Difference. Online Trading Facility. Issue Date: 28 May 2012 V5. ARUDA PTY LTD PRODUCT DISCLOSURE STATEMENT Over- the- Counter Contracts for Difference Online Trading Facility Issue Date: 28 May 2012 V5. IMPORTANT INFORMATION Financial Services are provided by Aruda

More information

Margin FX and CFDs Product Disclosure Statement 26 June 2015

Margin FX and CFDs Product Disclosure Statement 26 June 2015 Margin FX and CFDs 26 June 2015 Issuer: Forex Capital Trading Pty Ltd AFSL No. 306400 and ABN 69 119 086 270 1 P a g e 1. Important Information 1.1 About this PDS This PDS is issued by Forex Capital Trading

More information

DMM FX CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT

DMM FX CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT DMM FX CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT DMM FX Australia Pty Limited ACN 160 659 290 AFSL 437734 Issue Date: 7 November 2015 Version 2.0 Table of Contents Section 1 Important Information

More information

Section 1 Important Information... 2. Section 2 Regulatory Guide 227... 2. Section 3 Features... 3. Section 4 How to Trade... 8

Section 1 Important Information... 2. Section 2 Regulatory Guide 227... 2. Section 3 Features... 3. Section 4 How to Trade... 8 CONTENTS Section 1 Important Information... 2 Section 2 Regulatory Guide 227... 2 Section 3 Features... 3 Section 4 How to Trade... 8 Section 5 Significant Risks... 32 Section 6 Costs, Fees & Charges...

More information

26 th November, 2014. IC Markets CFDs and FOREX (etoro) PRODUCT DISCLOSURE STATEMENT

26 th November, 2014. IC Markets CFDs and FOREX (etoro) PRODUCT DISCLOSURE STATEMENT IC Markets CFDs and FOREX (etoro) PRODUCT DISCLOSURE STATEMENT International Capital Markets Pty Limited ABN 12 123 289 109 Australian Financial Services Licence No. 335 692 26 th November, 2014 International

More information

Product Disclosure Statement

Product Disclosure Statement Product Disclosure Statement Margin Foreign Exchange AND Contracts for Difference Issued on 21 July 2015 Issued by AVA CAPITAL MARKETS AUSTRALIA Pty Ltd ABN: 72 143 340 907 AFSL: 406684 www.avatrade.com.au

More information

Product Disclosure Statement

Product Disclosure Statement Product Disclosure Statement AND Issued on 10 November 2011 Issued by AVA CAPITAL MARKETS AUSTRALIA Pty Ltd ABN: 72 143 340 907 AFSL: 406684 www.avafx.com.au Please note: except where specified, this Product

More information

PRODUCT DISCLOSURE STATEMENT

PRODUCT DISCLOSURE STATEMENT PRODUCT DISCLOSURE STATEMENT Margin FX Contracts and CFDs Issuer: Goldland Capital Group Pty Ltd ABN 76 162 331 311 Australian Financial Services Licence No. 436416 Date: 8 September 2015 Page 1 TABLE

More information

PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE

PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE STA Global Investments Pty Ltd (ACN 158 641 064) Trading as Trade.com Level 29, 66 Goulburn Street Sydney NSW 2000 Australia PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE AUSTRALIAN FINANCIAL SERVICES

More information

PRODUCT DISCLOSURE STATEMENT

PRODUCT DISCLOSURE STATEMENT PRODUCT DISCLOSURE STATEMENT 1 JULY 2014 HIGHLOW MARKETS PTY LTD ACN: 143 553 628 +61 (0) 2 9186 9162 Level 14, Macquarie House, 167 Macquarie Street, Sydney, NSW 2000, Australia Copyright. Audax Legal

More information

PRODUCT DISCLOSURE STATEMENT FOR MARGIN FX & CONTRACTS FOR DIFFERENCE

PRODUCT DISCLOSURE STATEMENT FOR MARGIN FX & CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT FOR MARGIN FX & CONTRACTS FOR DIFFERENCE This document provides important information about Margined Foreign Exchange and Contracts for Difference contracts to help you decide

More information

Vanilla Options. Product Disclosure Statement. 21 May 2015

Vanilla Options. Product Disclosure Statement. 21 May 2015 Vanilla Options Product Disclosure Statement Issued by Western Union Business Solutions (Australia) Pty Limited (NZ Branch) (Company Number 3527631, FSP 168204) 21 May 2015 This document provides important

More information

Product Disclosure Statement

Product Disclosure Statement Product Disclosure Statement Margin Foreign Exchange AND Contracts For Difference (CFD s) Issued 15 of November 2015 by O.C.M. Online Capital Markets Pty Ltd Trading as XTrade ACN 140 899 476 AFSL 343628

More information

Combined Product Disclosure Statement Financial Services Guide for MahiFX Margin FX Trading

Combined Product Disclosure Statement Financial Services Guide for MahiFX Margin FX Trading Combined Product Disclosure Statement Financial Services Guide for MahiFX Margin FX Trading MahiFX Limited ARBN: 152 535 085 AFSL: 414198 Date: 28 August 2013 Version: 3.1 1. About this combined Product

More information

Contact Details Clients who wish to contact or correspond with Superforex Financial may use the following details:

Contact Details Clients who wish to contact or correspond with Superforex Financial may use the following details: Combined Financial Services Guide and Product Disclosure Statement Financial Services Guide Issue Date: 10 February 2014 This Financial Services Guide ( FSG ) is designed to provide you with important

More information

Product Disclosure Statement

Product Disclosure Statement Product Disclosure Statement Issuer: HiFX Limited An offer of a Derivative Foreign Exchange Swap Contract(s) (FX Swap(s)) Date: 29 July 2015 This document provides important information about HiFX Limited

More information

CONTRACTS FOR DIFFERENCE

CONTRACTS FOR DIFFERENCE CLIENT SERVICE AGREEMENT Halifax New Zealand Limited Client Service Agreement Product Disclosure Statement for CONTRACTS FOR DIFFERENCE Halifax New Zealand Limited Financial Services Provider No. 146605

More information

Product Disclosure Statement

Product Disclosure Statement Product Disclosure Statement 1. Contact Details Hantec Markets (Australia) Pty Ltd ACN 129 943 086 Address: Level 38, 2 Park Street Sydney NSW 2000 Australia Website: www.hantecmarkets.com Phone: +612

More information

PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE

PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE STA Global Investments Pty Ltd (ACN 158 641 064) Trading as Markets.com Level 29, 66 Goulburn Street Sydney NSW 2000 Australia PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE AUSTRALIAN FINANCIAL

More information

PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS GO MARKETS. first choice for forex

PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS GO MARKETS. first choice for forex PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS GO MARKETS first choice for forex TABLE OF CONTENTS 1. IMPORTANT INFORMATION... 1 NOTES AND DISCLAIMER... 1 HOW TO CONTACT US... 1 ELECTRONIC VERSION OF THE

More information

COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT

COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT SAXO CAPITAL MARKETS (AUSTRALIA) PTY LTD COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT Financial Services Guide PURPOSE AND CONTENT OF THIS FSG This FSG is prepared by Saxo Capital

More information

FP MARKETS CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT

FP MARKETS CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT FP MARKETS CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT Issue Date: 14 January 2013 First Prudential Markets Pty Ltd ABN 16 112 600 281 AFSL 286354 1 FP Markets Contracts For Difference Product

More information

Structured Options. Product Disclosure Statement

Structured Options. Product Disclosure Statement Structured Options Product Disclosure Statement STRUCTURED OPTIONS PRODUCT DISCLOSURE STATEMENT Issue Date: 29 June 2015 TABLE OF CONTENTS 1. PURPOSE 2. IMPORTANT INFORMATION 2.1 COPIES 2.2 UPDATES RELATING

More information

Vanilla Options. Product Disclosure Statement

Vanilla Options. Product Disclosure Statement Vanilla Options Product Disclosure Statement VANILLA OPTIONS PRODUCT DISCLOSURE STATEMENT Issue Date: 29 June 2015 TABLE OF CONTENTS 1. PURPOSE 2. IMPORTANT INFORMATION 2.1 COPIES 2.2 UPDATES RELATING

More information

How To Trade Cfds

How To Trade Cfds TD 365 Product Disclosure Statement (PDS) 28 th September 2015 Issued by Finsa Pty Limited (ACN 158065635) trading as TD 365, Australian financial services licence no. 422661 Page 1 of 65 Table of Contents

More information

Product Disclosure Statement

Product Disclosure Statement INGOT BROKERS (AUSTRALIA) PTY LTD Product Disclosure Statement Margin FX, CFD s and Futures 18 th October 2015 Ingot Brokers Pty. Ltd. AFSL: 428015 ABN: 87 159 895 431 Level 25, 88 Phillip Street Sydney

More information

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT Issue Date: 1 August 2014 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 1 Table of Contents

More information

PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE. Issued 16 November 2015 by FOREX FINANCIAL SERVICES PTY LTD ABN 84129217812 AFSL 323193

PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE. Issued 16 November 2015 by FOREX FINANCIAL SERVICES PTY LTD ABN 84129217812 AFSL 323193 PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE Issued 16 November 2015 by FOREX FINANCIAL SERVICES PTY LTD ABN 84129217812 AFSL 323193 1 IMPORTANT NOTE Financial Services are provided by, and this

More information

CAPITAL INDEX PTY LTD Product Disclosure Statement (PDS) 20 th April 2015

CAPITAL INDEX PTY LTD Product Disclosure Statement (PDS) 20 th April 2015 CAPITAL INDEX PTY LTD Product Disclosure Statement (PDS) 20 th April 2015 Issued by Capital Index Pty Limited (ACN 602584887) as an Authorised Representative of Finsa Pty Limited (AFSL no. 422661) Page

More information

Foreign Exchange Option Product Disclosure Statement. Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714

Foreign Exchange Option Product Disclosure Statement. Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714 Foreign Exchange Option Product Disclosure Statement Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714 Dated: 24 November 2014 Foreign Exchange Option Contents Important Information...

More information

PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS

PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS PRODUCT DISCLOSURE STATEMENT BINARY OPTIONS Issue Date 7 th January 2014 Version Number 1 You should read all sections of this Product Disclosure Statement before making a decision to acquire this financial

More information

Foreign Exchange and Drafts Transactions. Product Disclosure Statement

Foreign Exchange and Drafts Transactions. Product Disclosure Statement Foreign Exchange and Drafts Transactions Product Disclosure Statement FOREIGN EXCHANGE & DRAFT TRANSACTIONS PRODUCT DISCLOSURE STATEMENT Issue Date: 29 June 2015 TABLE OF CONTENTS 1. PURPOSE 2. IMPORTANT

More information

Foreign Exchange SOLD VANILLA PUT OPTION PRODUCT DISCLOSURE STATEMENT

Foreign Exchange SOLD VANILLA PUT OPTION PRODUCT DISCLOSURE STATEMENT ISSUED BY: ST.GEORGE BANK LIMITED AFS LICENCE NUMBER: 240997 EFFECTIVE DATE: 3 NOVEMBER 2008 Foreign Exchange SOLD VANILLA PUT OPTION IMPORTANT NOTICE Transactions involve various risks including movements

More information

ebridge Online Trading Facility

ebridge Online Trading Facility Futures Contracts For Difference Product disclosure Statement ebridge Online Trading Facility Issuer: StoneBridge Securities Limited ABN 92 067 161 755 Australian Financial Services Licence No. 238148

More information

FENIX FX MARKETS Product Disclosure Statement (PDS) 28 th September 2015

FENIX FX MARKETS Product Disclosure Statement (PDS) 28 th September 2015 FENIX FX MARKETS Product Disclosure Statement (PDS) 28 th September 2015 Issued by Finsa Pty Limited (ACN 158065635) trading as Fenix FX Markets, Australian financial services licence no. 422661 Page 1

More information

RUBIX FX MARKETS Product Disclosure Statement (PDS) 5 th October 2015

RUBIX FX MARKETS Product Disclosure Statement (PDS) 5 th October 2015 RUBIX FX MARKETS Product Disclosure Statement (PDS) 5 th October 2015 Issued by Finsa Pty Limited (ACN 158065635) trading as Rubix FX Markets, Australian financial services licence no. 422661 Page 1 of

More information

Product Disclosure Statement. Binary Options

Product Disclosure Statement. Binary Options Product Disclosure Statement Binary Options TABLE OF CONTENTS 1. Important Information... 3 NOTES AND DISCLAIMER... 3 HOW TO CONTACT US... 3 ELECTRONIC VERSION OF THE PDS... 3 UPDATED INFORMATION... 3

More information

COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT

COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT E-Trans Australia Pty Ltd AFSL 439303 COMBINED FINANCIAL SERVICES GUIDE AND PRODUCT DISCLOSURE STATEMENT Financial Services Guide Date: 30 April 2014 E-Trans Group Pty Ltd ABN 83 132 970 159 AFSL 439303

More information

PRODUCT DISCLOSURE STATEMENT COMMSEC CFDS

PRODUCT DISCLOSURE STATEMENT COMMSEC CFDS PRODUCT DISCLOSURE STATEMENT COMMSEC CFDS We re here to help To find out more, call us on 1300 307 853, from 8am Monday to 6am Saturday, email us at cfds@commsec.com.au or visit our website at commsec.com.au.

More information

Foreign Exchange Swap Supplementary Product Disclosure Statement 28 September 2009

Foreign Exchange Swap Supplementary Product Disclosure Statement 28 September 2009 Foreign Exchange Swap Supplementary Product Disclosure Statement 28 September 2009 This Supplementary Product Disclosure Statement ( SPDS ) is dated 28 September 2009 and is issued by Westpac Banking Corporation

More information

TD 365 Product Disclosure Statement (PDS) 17 th September 2013

TD 365 Product Disclosure Statement (PDS) 17 th September 2013 TD 365 Product Disclosure Statement (PDS) 17 th September 2013 Issued by Finsa Pty Limited (ACN 158065635) trading as TD 365, Australian financial services licence no. 422661) Table of Contents - Product

More information

Over-the-counter contracts for difference: Improving disclosure for retail investors

Over-the-counter contracts for difference: Improving disclosure for retail investors REGULATORY GUIDE 227 Over-the-counter contracts for difference: Improving disclosure for retail investors August 2011 About this guide This guide is for those involved with the issue, sale or advertising

More information

Finsa Pty Limited Product Disclosure Statement (PDS) 21 st September 2015

Finsa Pty Limited Product Disclosure Statement (PDS) 21 st September 2015 Finsa Pty Limited Product Disclosure Statement (PDS) 21 st September 2015 Issued by Finsa Pty Limited (ACN 158065635) Australian financial services licence no. 422661 Page 1 of 54 Table of Contents - Product

More information

PRODUCT DISCLOSURE STATEMENT

PRODUCT DISCLOSURE STATEMENT PRODUCT DISCLOSURE STATEMENT EIGHTCAP PTY LTD ABN 73 139 495 944 AFSL 391441 Suite 1913, Level 19, 180 Lonsdale Street, Melbourne, VIC 3000, Australia Phone: 03 8373 4800 Fax: 03 9623 2201 Email: customerservice@eightcap.com

More information

PRODUCT DISCLOSURE STATEMENT FOR THE ISSUE OF ASX CFDs BY MORRISON SECURITIES PTY LIMITED

PRODUCT DISCLOSURE STATEMENT FOR THE ISSUE OF ASX CFDs BY MORRISON SECURITIES PTY LIMITED PRODUCT DISCLOSURE STATEMENT FOR THE ISSUE OF ASX CFDs BY MORRISON SECURITIES PTY LIMITED PART 1 This document is part of a Product Disclosure Statement and is Part 1. The other document which makes up

More information

AAFX CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT

AAFX CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT AAFX CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT Issue Date: 7 August 2012 AYERS Alliance Securities Pty Limited ABN 81 149 475 105 AFSL 403070 AAFX_27417-10760-CFD PDS 1 Table of Contents Section

More information

MARGIN FOREIGN EXCHANGE & CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT. AxiCorp Financial Services Pty Ltd ACN 127 606 348 AFSL 318232

MARGIN FOREIGN EXCHANGE & CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT. AxiCorp Financial Services Pty Ltd ACN 127 606 348 AFSL 318232 MARGIN FOREIGN EXCHANGE & CONTRACTS FOR DIFFERENCE PRODUCT DISCLOSURE STATEMENT AxiCorp Financial Services Pty Ltd ACN 127 606 348 AFSL 318232 CONTENTS 1. IMPORTANT INFORMATION... 3 2. APPLYING TO TRADE

More information

Invast Financial Services

Invast Financial Services Invast Financial Services Financial Services Guide (FSG) for Equities, Spot Forex & CFDs Date: AFSL No 438 283 ABN 48 162 400 035 1 Invast Financial Service Guide (FSG) Purpose and content of this FSG:

More information

PRODUCT DISCLOSURE STATEMENT

PRODUCT DISCLOSURE STATEMENT PRODUCT DISCLOSURE STATEMENT AETOS Capital Group Pty Ltd Updated on 30 October 2015 V20151030 Table of Contents 1. Key information... 2 2. What are we authorised to do?... 3 3. Margin FX contracts... 3

More information

HY Markets Product Disclosure Statement

HY Markets Product Disclosure Statement HY Markets Product Disclosure Statement 18 th December 2012 Issued by Henyep Capital Markets (UK) Limited (ABN 157 707 287, Australian financial services licence no. 423082) http://www.hymarkets.com.au

More information

RIM SECURITIES LIMITED FINANCIAL SERVICES GUIDE ABN 86 111 273 048 AFS Licence No. 283119

RIM SECURITIES LIMITED FINANCIAL SERVICES GUIDE ABN 86 111 273 048 AFS Licence No. 283119 RIM SECURITIES LIMITED FINANCIAL SERVICES GUIDE ABN 86 111 273 048 AFS Licence No. 283119 Effective: 22 September 2014 INTRODUCTION This Financial Services Guide ( FSG ) is designed to assist you in deciding

More information

Macquarie Contracts for Difference

Macquarie Contracts for Difference Macquarie Contracts for Difference Product Disclosure Statement 15 JUNE 2015 Macquarie Bank Limited. ABN 46 008 583 542. Australian Financial Services Licence No. 237502. 1 This PDS This product disclosure

More information

CONTRACTS FOR DIFFERENCE IRESS PRODUCT DISCLOSURE STATEMENT

CONTRACTS FOR DIFFERENCE IRESS PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE IRESS PRODUCT DISCLOSURE STATEMENT Issue Date: 1st May 2015 Contents Section 1: Important Information Page 3 Section 2: Key Information Page 5 Section 3: How to Trade Page 12 Section

More information

Macquarie Shorting. Product Disclosure Statement 15 JUNE 2015

Macquarie Shorting. Product Disclosure Statement 15 JUNE 2015 Macquarie Shorting Product Disclosure Statement 15 JUNE 2015 Macquarie Bank Limited. ABN 46 008 583 542. Australian Financial Services Licence No. 237502. 1 This PDS This product disclosure statement (

More information

Foreign Currency Options. Product Disclosure Statement. 1 December 2015

Foreign Currency Options. Product Disclosure Statement. 1 December 2015 . Product Disclosure Statement. 1 December 2015 Product Disclosure Statement About this document Issuer The issuer of the products described in this PDS is Bendigo and Adelaide Bank Limited, ABN 11 068

More information

CMC Markets Stockbroking Limited Exchange Traded Options Product Disclosure Statement (PDS)

CMC Markets Stockbroking Limited Exchange Traded Options Product Disclosure Statement (PDS) CMC Markets Stockbroking Limited Exchange Traded Options Product Disclosure Statement (PDS) 16 May 2011 AFSL No. 246381 and ABN 69 081 002 851 Table of contents Table of contents Part 1 01 General introduction

More information

PRODUCT DISCLOSURE STATEMENT FOREIGN EXCHANGE

PRODUCT DISCLOSURE STATEMENT FOREIGN EXCHANGE STA Global Investments Pty Ltd (ACN 158 641 064) Trading as Markets.com Level 29, 66 Goulburn Street Sydney NSW 2000 Australia PRODUCT DISCLOSURE STATEMENT FOREIGN EXCHANGE AUSTRALIAN FINANCIAL SERVICES

More information

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT Issue Date: 23 March 2016 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 1 Table of Contents

More information

FINANCIAL SERVICES GUIDE

FINANCIAL SERVICES GUIDE FINANCIAL SERVICES GUIDE VERSION 3.1 15 th September 2015 1 of 10 Table of Contents 1. Issue Date... 3 2. Purpose and Contents of this FSG... 3 3. Name of Service Provider and Contact Details... 3 4. Australian

More information

Foreign Exchange Transaction Product Disclosure Statement. Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714

Foreign Exchange Transaction Product Disclosure Statement. Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714 Foreign Exchange Transaction Product Disclosure Statement Issued by Westpac Banking Corporation ABN 33 007 457 141 AFSL 233714 Dated : 13 February 2015 278153\11.0278153\11.0 Foreign Exchange Transaction

More information

TABLE OF CONTENTS. 1. Important Information... 4 NOTES AND DISCLAIMER... 4 HOW TO CONTACT US... 4 ELECTRONIC VERSION OF THE PDS...

TABLE OF CONTENTS. 1. Important Information... 4 NOTES AND DISCLAIMER... 4 HOW TO CONTACT US... 4 ELECTRONIC VERSION OF THE PDS... TABLE OF CONTENTS 1. Important Information... 4 NOTES AND DISCLAIMER... 4 HOW TO CONTACT US... 4 ELECTRONIC VERSION OF THE PDS... 4 UPDATED INFORMATION... 4 TREATMENT OF OVERSEAS APPLICANTS... 4 RESTRICTIONS

More information

Forex TG Pty Ltd PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE AND CONTRACTS FOR DIFFERENCE. Page 1

Forex TG Pty Ltd PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE AND CONTRACTS FOR DIFFERENCE. Page 1 Forex TG Pty Ltd PRODUCT DISCLOSURE STATEMENT MARGIN FOREIGN EXCHANGE AND CONTRACTS FOR DIFFERENCE Page 1 MARGIN FOREIGN EXCHANGE AND CONTRACTS FOR DIFFERENCES PRODUCT DISCLOSURE STATEMENT Please note:

More information

CMC Markets NZ Limited. Next Generation Platform Risk Warning Notice. 31 May 2015. CMC Markets NZ Limited Risk Warning Notice 1

CMC Markets NZ Limited. Next Generation Platform Risk Warning Notice. 31 May 2015. CMC Markets NZ Limited Risk Warning Notice 1 CMC Markets NZ Limited Next Generation Platform Risk Warning Notice 31 May 2015 CMC Markets NZ Limited Risk Warning Notice 1 Significant risks of trading CFDs This document sets the major risks that can

More information

Dimensional Short Term Fixed Interest Trust

Dimensional Short Term Fixed Interest Trust Dimensional Short Term Fixed Interest Trust PRODUCT DISCLOSURE STATEMENT Issued by DFA Australia Limited ( Dimensional ) ABN 46 065 937 671 APIR DFA0100AU Australian Financial Services Licence number:

More information

How To Make Money On Direct Fx Trading

How To Make Money On Direct Fx Trading PRODUCT DISCLOSURE STATEMENT CONTRACTS FOR DIFFERENCE & MARGIN FX CONTRACTS DIRECT FX TRADING Pty Ltd ACN 120 189 422 AFSL No. 305 539 Level 2, 19-21 Hunter Street SYDNEY NSW 2000 Page 1 of 36 PRODUCT

More information

Product Disclosure Statement ("PDS")

Product Disclosure Statement (PDS) Product Disclosure Statement ("PDS") LICENCE NO: 246566 ISSUER: EASY FOREX PTY LIMITED ISSUE DATE: 28 March 2012 (Version 2.6) The information and any general advice in this PDS do not take into account

More information

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT

OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT OANDA AUSTRALIA PTY LTD PRODUCT DISCLOSURE STATEMENT Issue Date: 5 August 2015 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 OANDA Australia Pty Ltd ACN 152 088 349 AFSL 412981 1 Table of Contents

More information

How To Buy A Non Deliverable Option From Westpac

How To Buy A Non Deliverable Option From Westpac Non-Deliverable Option Transactions Product Disclosure Statement Issued by Westpac Banking Corporation Australian Financial Services Licence No. 233714 ABN 33 007 457 141 Dated 8 March 2012 Non-Deliverable

More information

Vanguard High Growth Index Fund

Vanguard High Growth Index Fund Product Disclosure Statement 28 August 2013 Vanguard High Growth Index Fund This Product Disclosure Statement (PDS) is issued by Vanguard Investments Australia Ltd ABN 72 072 881 086 AFSL 227 263 (Vanguard,

More information

MERCER GLOBAL LOW VOLATILITY SHARES FUND Product Disclosure Statement

MERCER GLOBAL LOW VOLATILITY SHARES FUND Product Disclosure Statement MERCER GLOBAL LOW VOLATILITY SHARES FUND Product Disclosure Statement 1 June 2015 ARSN: 154 973 154 APIR: MIN0083AU Contents Page 1. About Mercer Investments (Australia) Limited 2 2. How the Mercer Global

More information

NAB Foreign Exchange Transactions. Full Participation FX Solutions Products Product Disclosure Statement

NAB Foreign Exchange Transactions. Full Participation FX Solutions Products Product Disclosure Statement NAB Foreign Exchange Transactions Full Participation FX Solutions Products Product Disclosure Statement Effective date of issue 3 September 2012 Important information Issuer and contact details This Product

More information

General Risk Disclosure

General Risk Disclosure General Risk Disclosure Colmex Pro Ltd (hereinafter called the Company ) is an Investment Firm regulated by the Cyprus Securities and Exchange Commission (license number 123/10). This notice is provided

More information

The mechanics of the warrants market

The mechanics of the warrants market Course #: Title Course 01a The mechanics of the warrants market Topic 1: What are warrants?... 3 The ASX Warrants market... 3 Topic 2: Warrant features... 4 Underlying... 4 Exercise price (final payment)...

More information

PRODUCT DISCLOSURE STATEMENT. ILQ Australia PTY LTD. Margin FX ACN: 159 166 739 AFSL: 424122

PRODUCT DISCLOSURE STATEMENT. ILQ Australia PTY LTD. Margin FX ACN: 159 166 739 AFSL: 424122 PRODUCT DISCLOSURE STATEMENT Margin FX ILQ Australia PTY LTD ACN: 159 166 739 AFSL: 424122 Address: Level 36, 1 Macquarie Place, Sydney, New South Wales 2000 AU Telephone#: +61 2 8607 8364 International:

More information

Financial Services Guide (FSG)

Financial Services Guide (FSG) CMC Markets Asia Pacific Pty Ltd Financial Services Guide (FSG) 12 December 2014 AFSL No. 238054 and ABN 11 100 058 213 Table of Contents Table of contents 01 CMC Markets Asia Pacific Pty Ltd 02 Purpose

More information

Schroders Schroder Global Blend Fund

Schroders Schroder Global Blend Fund Schroders Schroder Global Blend Fund Product Disclosure Statement Issued 27 October 2014 Contact details Schroder Investment Management Australia Limited (ABN 22 000 443 274) (AFSL No: 226 473) Registered

More information

CFD Disclosure Document Marketmaker TM (DD)

CFD Disclosure Document Marketmaker TM (DD) CMC Markets NZ Limited CFD Disclosure Document Marketmaker TM (DD) 9 March 2013 Company Registration Number 1705324 Table of contents Table of contents 01 Important information 5 1.1 About this DD 1.2

More information

KEY POLICIES FOR CFDS Issue Date: May 2016

KEY POLICIES FOR CFDS Issue Date: May 2016 KEY POLICIES FOR CFDS Issue Date: May 2016 Contents 1. About this document 3 2. Client Suitability Policy 4 The purpose of this Policy 4 Minimum qualifying criteria 4 Context 4 Suitability Process 5 Personal

More information

Financial Services Guide

Financial Services Guide Financial Services Guide 9 th July 2014 The provider of the services described in this Financial Services Guide is Sharelord Investor Pty Ltd ABN 36 162 669 883 as authorised representative (437618) of

More information

Important Information

Important Information Russell High Growth Fund Class C ARSN: 111 170 122 APIR: RIM0030AU 1 June 2015 Important Information Contents 1. About Russell Investment Management Ltd... 2 2. How the Fund works... 2 3. Benefits of investing

More information

ANZ PRIVATE INVESTMENT MANAGEMENT SERVICE

ANZ PRIVATE INVESTMENT MANAGEMENT SERVICE ANZ PRIVATE INVESTMENT MANAGEMENT SERVICE PRODUCT DISCLOSURE STATEMENT DATED 22 DECEMBER 2015 SEPARATELY MANAGED ACCOUNTS ARSN 114 818 530 PRAEMIUM AUSTRALIA LIMITED ABN 92 117 611 784 AUSTRALIAN FINANCIAL

More information

CFD Product Disclosure Statement Next Generation Platform (PDS)

CFD Product Disclosure Statement Next Generation Platform (PDS) CMC Markets Asia Pacific Pty Ltd CFD Product Disclosure Statement Next Generation Platform (PDS) 24 January 2015 AFSL No. 238054 and ABN 11 100 058 213 Table of contents Table of contents 1 Important information

More information

Invast. Spot Forex and CFDs. 18 July 2013 AFSL No. 438283 ABN 48 162 400 035

Invast. Spot Forex and CFDs. 18 July 2013 AFSL No. 438283 ABN 48 162 400 035 Invast Financial Services Spot Forex and CFDs Product Disclosure Statement (PDS) MT4, ctrader & ST24 18 July 2013 AFSL No. 438283 ABN 48 162 400 035 You can contact Invast Financial Services ( Invast )

More information

Futures Supplementary Product Disclosure Statement

Futures Supplementary Product Disclosure Statement Futures Supplementary Product Disclosure Statement Issued by Macquarie Equities Limited (ABN 41 002 574 923 Australian Financial Services Licence No. 237504) Date of issue 27 June 2014 Macquarie Private

More information

Response to submissions on CP 146 OTC CFDs: Improving disclosure for retail investors

Response to submissions on CP 146 OTC CFDs: Improving disclosure for retail investors REPORT 246 Response to submissions on CP 146 OTC CFDs: Improving disclosure for retail investors August 2011 About this report This report highlights the key issues that arose out of the submissions received

More information

Futures Supplementary Product Disclosure Statement

Futures Supplementary Product Disclosure Statement Futures Supplementary Product Disclosure Statement Issued by Macquarie Equities Limited (ABN 41 002 574 923 Australian Financial Services Licence No. 237504) DATE OF ISSUE 15 JULY 2016 macquarie.com Macquarie

More information

Financial Services Guide

Financial Services Guide Financial Services Guide 1. The Purpose of This Financial Services Guide This Financial Services Guide ( FSG ) is an important document. Please read it carefully and ensure that you understand it. Azure

More information

Schroders Schroder Global Core Fund

Schroders Schroder Global Core Fund Schroders Schroder Global Core Fund Product Disclosure Statement Issued 31 March 2015 Contact details Schroder Investment Management Australia Limited (ABN 22 000 443 274) (AFSL No: 226 473) Registered

More information

FINANCIAL SERVICES GUIDE

FINANCIAL SERVICES GUIDE FINANCIAL SERVICES GUIDE Version 2.0 Dated 23 April 2014 CAPITAL 19 GLOBAL INVESTMENTS R E A L I S E T H E G R O W T H P O T E N T I A L O F I N V E S T I N G I N G L O B A L M A R K E T S 1 FINANCIAL

More information

Magellan Global Fund. Product Disclosure Statement 16 June 2014. Contents. Contact Details ARSN 126 366 961 APIR MGE0001AU

Magellan Global Fund. Product Disclosure Statement 16 June 2014. Contents. Contact Details ARSN 126 366 961 APIR MGE0001AU Magellan Global Fund ARSN 126 366 961 APIR MGE0001AU Product Disclosure Statement 16 June 2014 Issued by Magellan Asset Management Limited ABN 31 120 593 946, AFS Licence No. 304 301 Contents 1. About

More information

Foreign Exchange Forward Transactions for the nabtrade Global Market Trading service Product Disclosure Statement

Foreign Exchange Forward Transactions for the nabtrade Global Market Trading service Product Disclosure Statement Foreign Exchange Forward Transactions for the nabtrade Global Market Trading service Product Disclosure Statement Issued by National Australia Bank Limited (NAB) ABN 12 004 044 937, AFSL 230686 Effective

More information

Product Disclosure Statement. WHAT YOU NEED TO KNOW Flexible Forward Cash Settled. Issue date: 12 March 2014 Issued by:

Product Disclosure Statement. WHAT YOU NEED TO KNOW Flexible Forward Cash Settled. Issue date: 12 March 2014 Issued by: WHAT YOU NEED TO KNOW Flexible Forward Cash Settled Product Disclosure Statement Issue date: 12 March 2014 Issued by: Commonwealth Bank of Australia ABN 48 123 123 124 AFSL 234945 You should read all sections

More information

Financial Services Guide

Financial Services Guide Financial Services Guide Phillip Capital Limited AFSL No. 246827 - ABN 14 002 918 247 Phillip Capital Trading Pty Ltd AFSL No. 246796 - ABN 68 066 066 911 (together Phillip Capital ) Purpose of the Financial

More information

Macquarie Index Tracking Global Bond Fund Product Disclosure Statement

Macquarie Index Tracking Global Bond Fund Product Disclosure Statement Macquarie Index Tracking Global Bond Fund Investment Management 4 July 206 Macquarie Index Tracking Global Bond Fund Product Disclosure Statement Contents. About Macquarie Investment Management Australia

More information

TABLE OF CONTENTS. 1. Important Information... 5 NOTES AND DISCLAIMER... 5 HOW TO CONTACT US... 5 ELECTRONIC VERSION OF THE PDS...

TABLE OF CONTENTS. 1. Important Information... 5 NOTES AND DISCLAIMER... 5 HOW TO CONTACT US... 5 ELECTRONIC VERSION OF THE PDS... TABLE OF CONTENTS 1. Important Information... 5 NOTES AND DISCLAIMER... 5 HOW TO CONTACT US... 5 ELECTRONIC VERSION OF THE PDS... 5 UPDATED INFORMATION... 5 TREATMENT OF OVERSEAS APPLICANTS... 5 RESTRICTIONS

More information